Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript May 6, 2024 Axsome Therapeutics, Inc. misses on earnings expectations. Reported…
Read More »Therapeutics
In a recent transaction, Martine Rothblatt, the Chairperson and CEO of United Therapeutics Corp (NASDAQ:), sold a significant amount of…
Read More »Biora Therapeutics (NASDAQ:BIOR) Monday announced the issuance of a new patent related to the company’s BioJet platform for oral, systemic…
Read More »Therapeutics MD press release (NASDAQ:TXMD): FY net loss from continuing operations was $7.7 million, or $0.74 per basic and diluted…
Read More »Agile Therapeutics (NASDAQ:AGRX) on Monday said the company has received a final delisting notice from Nasdaq. The delisting is a…
Read More »Â© Reuters. Tuesday, Silence Therapeutics (NASDAQ:SLN) maintained its Outperform rating and $67.00 price target from BMO Capital. The firm’s continued…
Read More »Merck (NYSE:MRK) is reportedly in advanced talks to buy immuno-oncology company Harpoon Therapeutics (NASDAQ:HARP) for around $700M. Citing people familiar…
Read More »GreenApple78 Applied Therapeutics (NASDAQ:APLT) stock plunged 30% in post-market trading Thursday after the biotech company reported mixed results from a…
Read More »Â© Reuters. Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon.…
Read More »